Popular Press
Sirolimus-tacrolimus Combination Immunosuppression
The Lancet
(2000)
Abstract
A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.
Keywords
- Drug Therapy,
- Graft Rejection,
- Immunosuppressive Agents,
- Kidney Transplantation,
- Liver Transplantation,
- Pancreas Transplantation,
- Sirolimus,
- Tacrolimus
Disciplines
Publication Date
January 29, 2000
Publisher Statement
Dr. Vivian McAlister is currently a faculty member at The University of Western Ontario.
Citation Information
Vivian C. McAlister, Zuhua Gao, Kevork Peltekian, Javier Domingues, et al.. "Sirolimus-tacrolimus Combination Immunosuppression" The Lancet Vol. 355 Iss. 9201 (2000) Available at: http://works.bepress.com/vivianmcalister/56/